These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23927443)

  • 1. Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity.
    Jeon JO; Kim S; Choi E; Shin K; Cha K; So IS; Kim SJ; Jun E; Kim D; Ahn HJ; Lee BH; Lee SH; Kim IS
    ACS Nano; 2013 Sep; 7(9):7462-71. PubMed ID: 23927443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting.
    Kim S; Jeon JO; Jun E; Jee J; Jung HK; Lee BH; Kim IS; Kim S
    Biomacromolecules; 2016 Mar; 17(3):1150-9. PubMed ID: 26899206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-Chambered Ferritin Platform: Dual-Function Payloads of Cytotoxic Peptides and Fluorescent Protein.
    Kim S; Kim GS; Seo J; Gowri Rangaswamy G; So IS; Park RW; Lee BH; Kim IS
    Biomacromolecules; 2016 Jan; 17(1):12-9. PubMed ID: 26646195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide.
    Sarangthem V; Cho EA; Bae SM; Singh TD; Kim SJ; Kim S; Jeon WB; Lee BH; Park RW
    PLoS One; 2013; 8(12):e81891. PubMed ID: 24339977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
    Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent Targeting Based Delivery of Therapeutic Peptide using AP1-ELP Carrier for Effective Cancer Therapy.
    Sarangthem V; Kim Y; Singh TD; Seo BY; Cheon SH; Lee YJ; Lee BH; Park RW
    Theranostics; 2016; 6(12):2235-2249. PubMed ID: 27924160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing a better binding peptide for drug delivery targeting the interleukin-4 receptor.
    Bai XD; Cao XW; Chen YH; Fu LY; Zhao J; Wang FJ
    J Drug Target; 2020 Nov; 28(9):970-981. PubMed ID: 32363946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
    Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
    Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mimtags: the use of phage display technology to produce novel protein-specific probes.
    Ahmed N; Dhanapala P; Sadli N; Barrow CJ; Suphioglu C
    J Immunol Methods; 2014 Mar; 405():121-9. PubMed ID: 24530568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform.
    Moon H; Lee J; Min J; Kang S
    Biomacromolecules; 2014 Oct; 15(10):3794-801. PubMed ID: 25180761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Lyn-binding peptide inhibitor blocks eosinophil differentiation, survival, and airway eosinophilic inflammation.
    Adachi T; Stafford S; Sur S; Alam R
    J Immunol; 1999 Jul; 163(2):939-46. PubMed ID: 10395690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of (±)-praeruptorin A on airway inflammation, airway hyperresponsiveness and NF-κB signaling pathway in a mouse model of allergic airway disease.
    Xiong Y; Wang J; Wu F; Li J; Zhou L; Kong L
    Eur J Pharmacol; 2012 May; 683(1-3):316-24. PubMed ID: 22449378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
    Mitchell J; Dimov V; Townley RG
    Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
    Kawakami K; Leland P; Puri RK
    Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factors GATA-3 and RORγt are important for determining the phenotype of allergic airway inflammation in a murine model of asthma.
    Ano S; Morishima Y; Ishii Y; Yoh K; Yageta Y; Ohtsuka S; Matsuyama M; Kawaguchi M; Takahashi S; Hizawa N
    J Immunol; 2013 Feb; 190(3):1056-65. PubMed ID: 23293351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effect of IL-4 Receptor-Targeting Pro-Apoptotic Peptide (AP1-ELP-KLAK) in Glioblastoma Tumor Model.
    Sarangthem V; Yi A; Kim Y; Rehemtulla A; Lee BH; Jeon YH; Singh TD; Park RW
    Int J Nanomedicine; 2021; 16():5039-5052. PubMed ID: 34335025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-4 receptor: biochemical characterization of IL-4-binding molecules in a T cell line expressing large numbers of receptors.
    Keegan AD; Beckmann MP; Park LS; Paul WE
    J Immunol; 1991 Apr; 146(7):2272-9. PubMed ID: 2005396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cellular uptake of peptide-targeted nanoparticles through increased peptide hydrophilicity and optimized ethylene glycol peptide-linker length.
    Stefanick JF; Ashley JD; Bilgicer B
    ACS Nano; 2013 Sep; 7(9):8115-27. PubMed ID: 24003770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform.
    Kang HJ; Kang YJ; Lee YM; Shin HH; Chung SJ; Kang S
    Biomaterials; 2012 Jul; 33(21):5423-30. PubMed ID: 22542610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.